INC Research Holdings, Inc. (INCR) CEO Alistair Macdonald Sells 2,348 Shares of Stock
INC Research Holdings, Inc. (NASDAQ:INCR) CEO Alistair Macdonald sold 2,348 shares of the business’s stock in a transaction dated Monday, September 18th. The shares were sold at an average price of $54.60, for a total transaction of $128,200.80. Following the transaction, the chief executive officer now owns 99,453 shares in the company, valued at approximately $5,430,133.80. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.
Alistair Macdonald also recently made the following trade(s):
- On Thursday, August 17th, Alistair Macdonald sold 8,828 shares of INC Research Holdings stock. The shares were sold at an average price of $55.65, for a total transaction of $491,278.20.
- On Monday, July 3rd, Alistair Macdonald sold 10,555 shares of INC Research Holdings stock. The shares were sold at an average price of $58.38, for a total transaction of $616,200.90.
INC Research Holdings, Inc. (NASDAQ:INCR) opened at 53.80 on Wednesday. The company’s 50-day moving average is $56.00 and its 200-day moving average is $52.66. The company has a market cap of $2.91 billion, a P/E ratio of 32.97 and a beta of 1.41. INC Research Holdings, Inc. has a 12 month low of $40.65 and a 12 month high of $61.10.
INC Research Holdings (NASDAQ:INCR) last released its earnings results on Thursday, July 27th. The company reported $0.64 EPS for the quarter, hitting analysts’ consensus estimates of $0.64. The company had revenue of $258.10 million during the quarter, compared to analysts’ expectations of $256.76 million. INC Research Holdings had a net margin of 5.69% and a return on equity of 40.69%. INC Research Holdings’s revenue for the quarter was down .3% on a year-over-year basis. During the same period last year, the business earned $0.61 EPS. On average, equities research analysts expect that INC Research Holdings, Inc. will post $2.62 EPS for the current fiscal year.
ILLEGAL ACTIVITY WARNING: This piece of content was first published by Watch List News and is the sole property of of Watch List News. If you are accessing this piece of content on another website, it was illegally copied and reposted in violation of U.S. & international trademark and copyright legislation. The correct version of this piece of content can be accessed at https://www.watchlistnews.com/inc-research-holdings-inc-incr-ceo-alistair-macdonald-sells-2348-shares-of-stock/1575390.html.
A number of equities research analysts have weighed in on INCR shares. TheStreet cut shares of INC Research Holdings from a “b” rating to a “c” rating in a report on Friday, July 28th. BidaskClub cut shares of INC Research Holdings from a “strong-buy” rating to a “buy” rating in a report on Monday, July 24th. KeyCorp upgraded shares of INC Research Holdings from a “sector weight” rating to an “overweight” rating and set a $68.00 price objective on the stock in a report on Monday, June 5th. Jefferies Group LLC restated a “buy” rating and issued a $62.00 price objective on shares of INC Research Holdings in a report on Friday, June 16th. Finally, SunTrust Banks, Inc. upgraded shares of INC Research Holdings from a “hold” rating to a “buy” rating and upped their target price for the stock from $48.00 to $67.00 in a research note on Wednesday, May 31st. One research analyst has rated the stock with a sell rating, four have issued a hold rating and five have assigned a buy rating to the stock. INC Research Holdings presently has a consensus rating of “Hold” and a consensus target price of $63.79.
Hedge funds have recently added to or reduced their stakes in the stock. Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in INC Research Holdings by 14.8% in the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,765 shares of the company’s stock worth $103,000 after purchasing an additional 228 shares in the last quarter. Pacad Investment Ltd. acquired a new stake in INC Research Holdings in the 2nd quarter worth approximately $123,000. Riverhead Capital Management LLC acquired a new stake in INC Research Holdings in the 2nd quarter worth approximately $128,000. Victory Capital Management Inc. boosted its stake in INC Research Holdings by 17.6% in the 2nd quarter. Victory Capital Management Inc. now owns 2,377 shares of the company’s stock worth $139,000 after purchasing an additional 356 shares in the last quarter. Finally, Invictus RG acquired a new stake in INC Research Holdings in the 1st quarter worth approximately $115,000. Institutional investors own 98.97% of the company’s stock.
About INC Research Holdings
INC Research Holdings, Inc is a global contract research organization (CRO). The Company focuses on Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. The Company operates through two segments: Clinical Development Services and Phase I Services.
Receive News & Ratings for INC Research Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for INC Research Holdings Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.